Issue Date | Title | Author(s) | Source | WOS | Fulltext/Archive link |
---|---|---|---|---|---|
2020 | Clinical experience of tabelecleucel in patients with EBV plus primary (PID) or acquired immunodeficiency (AID) associated lymphoproliferative disease | Nikiforow, S.; Baiocchi, R.; Nasta, S.; Weng, W.; Loeb, D.; Mahadeo, K. M.; Whangbo, J.; Phuong, P.; Navarro, W.; Gamelin, L.; Sun, Y.; Guzman-Becerra, N.; Prockop, S. | Annals of Oncology |